These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 467803)

  • 1. Isolation of biologically active components from rabies and other envelope viruses.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1979; 42():93-8. PubMed ID: 467803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of hemagglutinin and neuraminidase from influenza virus membrane by column displacement electrophoresis (isotachophoresis) with preservation of their activities.
    Johansson G; Abusugra I; Lövgren K; Morein B
    Prep Biochem; 1988; 18(4):405-12. PubMed ID: 3231599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation of influenza virus hemagglutinin by solubilization with the nonionic detergent O-14].
    Krivorutchenko IuL; Krivoshein IuS; Azhitskiĭ GIu; Rud'ko AP
    Mikrobiol Zh (1978); 1987; 49(3):72-5. PubMed ID: 3150495
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of the Soviet detergents dezintegron-O and dezintegron-B for the solubilization of influenza virus glycoproteins].
    Krivorutchenko IuL; Krivoshein IuS; Andronovskaia IB; Kastrikina LN; Lonskaia NI; Rud'ko AP
    Mikrobiol Zh (1978); 1991; 53(3):96-100. PubMed ID: 1779909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Solubilization of glycoproteins from enveloped viruses by detergents].
    Berezin VE; Zaĭdes VM; Artamonov AF; Isaeva ES; Zhdanov VM
    Biokhimiia; 1986 May; 51(5):808-15. PubMed ID: 3708022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective solubilization of hemagglutinin and neuraminidase from influenza viruses.
    Bachmayer H
    Intervirology; 1975; 5(5):260-72. PubMed ID: 1225862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification of neuraminidase from influenza virus on an immunosorbent].
    Iakubov LA; Savich IM; Beklemishev AB
    Biokhimiia; 1984 Oct; 49(10):1588-93. PubMed ID: 6440594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
    Stech J
    Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant viruses of poultry as vector vaccines against fowl plague].
    Fuchs W; Veits J; Mettenleiter TC
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):160-6. PubMed ID: 16573206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents.
    Phelan MA; Mayner RE; Bucher DJ; Ennis FA
    J Biol Stand; 1980; 8(3):233-42. PubMed ID: 7410447
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of detergents on measurement of influenza A virus haemagglutinin content in inactivated influenza vaccine by single radial immunodiffusion.
    Bizhanov GI; Kastrikina LN; Lonskaya NI; Popov VF
    Acta Virol; 1988 May; 32(3):252-60. PubMed ID: 2902773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successive isolation of hemagglutinin and neuraminidase from influenza virus A/Kransnodar/101/59 (H2N2) using bromelain].
    Arbatskiĭ NP; Zheltova AP; Iurtov DV; Derevitskaia VA; Kochetkov NK
    Dokl Akad Nauk SSSR; 1989; 306(6):1490-3. PubMed ID: 2806058
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Kasel JA; Laver WG
    Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and purification of the biological active viral components, hemagglutinin and nucleoprotein-neuraminidase from some influenza A2 strains.
    Alexandrescu M; Handrache L; Moroşanu V; Vancea G; Ionescu L; Colev A; Duda R; Duca M
    Rev Roum Inframicrobiol; 1971; 8(2):43-8. PubMed ID: 5164576
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and studies of myxovirus glycoproteins.
    Berezin VA; Zaides VM; Artamonov AF; Isaeva ES; Zhdanov VM
    Arch Virol; 1985; 85(3-4):281-300. PubMed ID: 2992420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.